A vs LLY
Agilent Technologies vs Eli Lilly and Company — AI-powered side-by-side comparison
A
Agilent Technologies
70
Buy
VS
LLY
Eli Lilly and Company
68
Buy
| Metric | A | LLY |
|---|
| AI Score |
70
|
68
|
| Price |
$148.44
|
$1,180.33
|
| P/E Ratio |
29.77×
|
39.54×
|
| ROE |
19.3%
|
77.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
53.0%
|
84.0%
|
| Debt / Equity |
0.47×
|
1.62×
|
| Dividend Yield |
0.7%
|
0.6%
|
| RSI (14) |
72.2
|
57.1
|
| Beta |
1.229
|
0.506
|
| Expected Upside |
+0.4%
|
+5.8%
|
AI Committee View
Current Innellis committee reasoning for A versus LLY.
A leads by 2 points.
A scores 70/100 (Buy) versus LLY at 68/100 (Buy).
A Committee View
80% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- RSI at 72 is in overbought territory — Technical
- Bollinger bandwidth of 16.1% signals elevated volatility — Risk
LLY Committee View
75% agreement
4 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth